Emergence of aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis

Transplantation

Volumn 94, Issue 4, 2012, Pages 403-410

  Egli, Adrian ^a   Fuller, Jeff ^a   Humar, Atul ^a   Lien, Dale ^a   Weinkauf, Justin ^a   Nador, Roland ^a   Kapasi, Ali ^a   Kumar, Deepali ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antifungal therapy; Hematopoietic stem cell transplant; Immunosuppression; Solid organ transplantation

Indexed keywords

POSACONAZOLE; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; ASPERGILLUS CALIDOUSTUS INFECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMIC MYCOSIS;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PYRIMIDINES; RETROSPECTIVE STUDIES; RISK FACTORS; TRIAZOLES;

EID: 84865634864     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825992f0     Document Type: Review

References (30)

1. Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46.
2. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101.
3. Saracli MA, Mutlu FM, Yildiran ST, et al. Clustering of invasive Aspergillus ustus eye infections in a tertiary care hospital: a molecular epidemiologic study of an uncommon species. Med Mycol 2007; 45: 377.
4. Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9(suppl 4): S180.
5. Cadena J, Levine DJ, Angel LF, et al. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepato-toxicity and effectiveness. Am J Transplant 2009; 9: 2085.
6. Neoh CF, Snell GI, Kotsimbos T, et al. Antifungal prophylaxis in lung transplantationVa world-wide survey. Am J Transplant 2011; 11: 361.
7. Husain S, Zaldonis D, Kusne S, et al. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006; 8: 213.
8. Hosseini-Moghaddam SM, Husain S. Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010; 31: 222.
9. Pavie J, Lacroix C, Hermoso DG, et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 2005; 43: 4902.
10. Gene J, Azon-Masoliver A, Guarro J, et al. Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immu-nosuppressed patients. J Clin Microbiol 2001; 39: 1134.
11. Iwen PC, Rupp ME, Bishop MR, et al. Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J Clin Microbiol 1998; 36: 3713.
12. Panackal AA, Imhof A, Hanley EW, et al. Aspergillus ustus infections among transplant recipients. Emerg Infect Dis 2006; 12: 403.
13. Verweij PE, van den Bergh MF, Rath PM, et al. Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol 1999; 37: 1606.
14. Cabada MM, Nishi SP, Lea AS, et al. Concomitant pulmonary infection with Nocardia transvalensis and Aspergillus ustus in lung transplantation. J Heart Lung Transplant 2010; 29: 900.
15. Florescu DF, Iwen PC, Hill LA, et al. Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant 2009; 23: 116.
16. Varga J, Houbraken J, Van Der Lee HA, et al. Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot Cell 2008; 7: 630.
17. Husain S, Mooney ML, Danziger-Isakov L, et al. A 2010 working formulation for the standardization of definitions of infections in car-diothoracic transplant recipients. J Heart Lung Transplant 2011; 30: 361.
18. Olorunnipa O, Zhang AY, Curtin CM. Invasive aspergillosis of the hand caused by Aspergillus ustus: a case report. Hand (N Y) 2009; 5: 102.
19. Krishnan-Natesan S, Chandrasekar PH, Manavathu EK, et al. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbina-fine. Diagn Microbiol Infect Dis 2008; 62: 443.
20. Vagefi PA, Cosimi AB, Ginns LC, et al. Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. J Heart Lung Transplant 2008; 27: 131.
21. Stiller MJ, Teperman L, Rosenthal SA, et al. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J Am Acad Dermatol 1994; 31(2 pt 2): 344.
22. Bretagne S, Marmorat-Khuong A, Kuentz M, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997; 35: 7.
23. Azzola A, Passweg JR, Habicht JM, et al. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection. J Clin Microbiol 2004; 42: 4805.
24. Nakai K, Kanda Y, Mineishi S, et al. Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation. Ann Hematol 2002; 81: 593.
25. Baddley JW, Stroud TP, Salzman D, et al. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32: 1319.
26. Baddley JW, Marr KA, Andes DR, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47: 3271.
27. Alastruey-Izquierdo A, Cuesta I, Houbraken J, et al. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. Med Mycol 2010; 48: 97.
28. Hageskal G, Kristensen R, Fristad RF, et al. Emerging pathogen Aspergillus calidoustus colonizes water distribution systems. Med Mycol 2011; 49: 588.
29. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813.
30. Canton E, Espinel-Ingroff A, Peman J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther 2009; 7: 107.